Daryl Faulkner's Net Worth

$6.82 Million

Estimate Recalculated Sep 18, 2024 03:33PM EST

Who is Daryl Faulkner?

Daryl Faulkner has an estimated net worth of $6.82 Million. This is based on reported shares across multiple companies, which include AspenBio Pharma, Inc., GenMark Diagnostics, Inc., DIGENE CORP, and INVITROGEN CORP.

SEC CIK

Daryl Faulkner's CIK is 0001203763

Past Insider Trading and Trends

2005 was Daryl Faulkner's most active year for acquiring shares with 54 total transactions. Daryl Faulkner's most active month to acquire stocks was the month of July. 2005 was Daryl Faulkner's most active year for disposing of shares, totalling 67 transactions. Daryl Faulkner's most active month to dispose stocks was the month of July. 2005 saw Daryl Faulkner paying a total of $15,085,514.41 for 286,474 shares, this is the most they've acquired in one year. In 2005 Daryl Faulkner cashed out on 356,992 shares for a total of $29,091,613.10, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Venaxis, Inc. (RIOT) Snapshot price: $6.4

CEO and Executive Chairman

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 9
Form 4
—
0
—
—
0
Jan 12
Form 4
—
0
—
—
0
Jan 6
Form 4
—
0
—
—
0
Jan 23
Form 4
—
0
—
—
0
Dec 11
Form 4
—
0
—
—
0
Apr 2
Form 4
—
0
—
—
0
Jan 5
Form 4
—
0
—
—
0
Jan 19
Form 4
∞
10K
$1.55
$15,500.00
10K
May 19
Form 3
—
0
—
—
0
No matching records found

GenMark Diagnostics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-133.87K
$24.05
-$3,219,597.55
0
Apr 22
Form 4
+5.85%
7.4K
—
—
133.87K
Feb 18
Form 4
+11.61%
13.15K
—
—
126.47K
May 29
Form 4
+7.12%
7.53K
$9.27
-$7.60
113.32K
Apr 29
Form 4
+21.41%
18.66K
—
—
105.79K
May 31
Form 4
+25.52%
17.71K
—
—
87.13K
May 24
Form 4
+11.90%
7.38K
—
—
69.42K
May 25
Form 4
+17.02%
9.02K
—
—
62.03K
May 26
Form 4
+8.16%
4K
$7.33
$29,320.00
53.01K
Oct 29
Form 4
+16.34%
6.88K
—
—
49.01K
May 28
Form 4
+15.79%
5.74K
—
—
42.13K
May 29
Form 4
+14.50%
4.61K
—
—
36.38K
May 22
Form 4
+18.67%
5K
$4.20
$21,000.00
31.78K
Jun 26
Form 4
+60.67%
10.11K
—
—
26.78K
Jun 6
Form 4
—
0
—
—
0
Jan 3
Form 4
∞
16.67K
$6.00
$99,996.00
16.67K
Jun 3
Form 4
—
0
—
—
0
May 28
Form 3
—
0
—
—
0
No matching records found

DIGENE CORP No price found

CEO and President

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+124.98%
1.69K
$61.26
-$54,521.40
3.04K
Jul 19
Form 4
∞
1.35K
$47.01
-$33,471.12
1.35K
May 3
Form 4
—
0
—
—
0
Dec 11
Form 3
—
0
—
—
0
No matching records found

INVITROGEN CORP No price found

Senior Vice President

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Form 4
+702.02%
65.18K
$68.80
$1,772,288.39
74.46K
Aug 23
Form 4
-87.53%
-65.18K
$81.90
-$5,337,749.16
9.28K
Aug 23
Form 4
+702.02%
65.18K
$68.80
$1,772,288.39
74.46K
Aug 23
Form 4
+2.34%
212
$50.28
$10,658.83
9.28K
Apr 30 - May 13
Form 4
+49.41%
3K
$31.84
$95,520.00
9.07K
Mar 14
Form 4
+3.58%
210
$50.28
$10,558.28
6.07K
Jan 31 - Mar 7
Form 4
+4.16%
234
$24.01
$5,618.93
5.86K
Oct 31 - Nov 12
Form 4
+48.50%
1.84K
$31.84
$58,521.92
5.63K
Sep 17
Form 4
+25.58%
772
$24.01
$18,537.65
3.79K
Apr 30 - May 14
Form 4
+19.24%
487
$54.83
-$2,141,276.61
3.02K
Oct 31 - Apr 26
Form 4
+51.92%
865
$23.80
$20,589.35
2.53K
Oct 31 - Oct 15
No matching records found